Broadcast Date: December 21, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Spheroids and organoids have significant advantages over traditional two-dimensional (2D) cell cultures, in large part because of their ability to better mimic the architecture of tissue and organs and the in vivo microenvironment. The realistic cellular arrangement makes it possible to study biological behaviors as cell-cell interactions and cell migration in a physiologically meaningful context. Access to this information has important implications for developing personalized medicines and targeted therapies for a wide range of diseases.
In this GEN webinar, Corning Life Sciences’ Hilary Sherman will discuss the advantages of spheroid and organoid models over traditional 2D models and highlight why they are best option for biomedical research and drug development. During the webinar, you’ll learn about the variety of tools available for working with 3D culture and helpful tips for selecting the right tools for different applications.
A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.
Webinar produced with support from: